The Alliance for Patient Access / What's New / ***PRESS RELEASE*** STATEMENT FROM ALLIANCE FOR PATIENT ACCESS ON DRUG IMPORTATION BILL

***PRESS RELEASE*** STATEMENT FROM ALLIANCE FOR PATIENT ACCESS ON DRUG IMPORTATION BILL

Physician organization urges lawmakers to prioritize access to safe, approved medications.

WASHINGTON – The Alliance for Patient Access (AfPA) made the following statement about the Senate bill introduced by Senators Booker, Casey and Sanders regarding the importation of prescription drugs from other countries.

STATEMENT FROM BRIAN KENNEDY, EXECUTIVE DIRECTOR, ALLIANCE FOR PATIENT ACCESS:
“The Senate bill introduced today that would allow the importation of drugs from other countries jeopardizes patients’ ability to access safe, FDA approved medicines. When drugs enter our country without going through FDA approval the drug supply is adulterated and physicians may lose confidence in the medications they prescribe to patients.

“The U.S. drug market is one of the safest in the world because of the extensive FDA approval process. Drugs imported from foreign countries aren’t subject to FDA regulation, including meeting the standards for safety and efficacy, so health care providers would have to consider the possibility of counterfeit medications and drugs of substandard quality.

“We urge the Senate to reject this bill because patient safety and access must be a top priority.”

###

The Alliance for Patient Access is a national network of physicians dedicated to ensuring patient access to approved therapies and appropriate clinical care.

About AfPA Digital

The Alliance for Patient Access is a national network of physicians dedicated to ensuring patient access to approved therapies and appropriate clinical care.
Back to Top